(Total Views: 672)
Posted On: 09/07/2024 1:04:57 AM
Post# of 148878
Ohm, Feb 2020:
"Patient #2: Enrolled in single IND. Patient is MBC with HER2+ stage 4 metastasis to lung, liver, and brain. Patient’s radiologist cancelled 2nd round of treatment due to leronlimab’s effect on shrinking the largest tumor in the brain by 56% and other lesions being stable. Leronlimab has, and continues to be, the only treatment in place since the measurement of brain tumor shrinkage was initiated."
"New data from Patient #2 with Stage 4 MBC and who has been treated with 10 weekly doses of leronlimab showed zero CTCs and zero EMTs, in addition to the shrinkage or disappearance of some brain metastases as previously reported."
https://markets.businessinsider.com/news/stoc...1028906220
___________
This is playing a big role in my excitement for addtl frwd news on him.
Although everyone is of course different too.
Ok, so radiation would be LL's spot & " A further shrinking of the tumor or even stasis would be excellent."
Yes sir.
Yes sir.
Thx as usual!
"Patient #2: Enrolled in single IND. Patient is MBC with HER2+ stage 4 metastasis to lung, liver, and brain. Patient’s radiologist cancelled 2nd round of treatment due to leronlimab’s effect on shrinking the largest tumor in the brain by 56% and other lesions being stable. Leronlimab has, and continues to be, the only treatment in place since the measurement of brain tumor shrinkage was initiated."
"New data from Patient #2 with Stage 4 MBC and who has been treated with 10 weekly doses of leronlimab showed zero CTCs and zero EMTs, in addition to the shrinkage or disappearance of some brain metastases as previously reported."
https://markets.businessinsider.com/news/stoc...1028906220
___________
This is playing a big role in my excitement for addtl frwd news on him.
Although everyone is of course different too.
Ok, so radiation would be LL's spot & " A further shrinking of the tumor or even stasis would be excellent."
Yes sir.
Yes sir.
Thx as usual!
(8)
(0)Scroll down for more posts ▼
